Comparison of karyotype analysis and RT-PCR for AML1/ETO in 204 unselected patients with AML

Annals of Hematology

Volumn 76, Issue 3-4, 1998, Pages 139-143

  Mitterbauer, M ^a   Kusec, R ^a   Schwarzinger, I ^a   Haas, O A ^b   Lechner, K ^a   Jaeger, U ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Acute myeloid leukemia; AML1 ETO; Reverse transcription polymerase chain reaction; t(8; 21)

Indexed keywords

MESSENGER RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW; CHROMOSOME 21; CHROMOSOME 8; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DIPLOIDY; FEMALE; GENE REARRANGEMENT; HUMAN; INTERMETHOD COMPARISON; KARYOTYPE; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; RELAPSE; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; CORE BINDING FACTOR ALPHA 2 SUBUNIT; FEMALE; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0031978688     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050378     Document Type: Article

References (44)

1. Andrieu V, Radford-Weiss I, Troussard X, Chane C, Valensi F, Guesnu M, Haddad E, Viguier F, Dreyfus F, Varet B, Flandrin G, Macintyre E (1996) Molecular detection of t(8;21)/AML-ETO in AML M1/M2:correlation with cytogenetics. morpholoey and immunophenotype. Br J Haematol 92:855-865
2. Bennett JM, Catovsky D, Daniel MT, Flandrian G, Galton DAG, Gralnick HR, Sultan C (1985) Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med 103:620-625
3. Berger R, Flandrin G, Bernheim A, Le Coniat M, Vecchione D, Pacot A, Derre J, Daniel M-T, Valensi F, Sigaux F, Ochoa-Noguera ME (1987) Cytogenetic studies on 519 consecutive de novo acute nonlymphoblastic leukemias. Cancer Genet Cytogenet 29:9-21
4. Bitter MA, LeBeau MM, Rowley JD, Larson RA, Golomb HM, Vardiman JW (1987) Association between morphology, karyotype and clinical features in myeloid leukemias. Hum Pathol 18:211-225
5. Bloomfield CD, Lawrence D, Arthur DC, Berg DT, Schiffwe CA, Mayer RJ (1994) Curative impact of intensification with high-dose cytarabine (HiDAC) in acute myeloid leukemia (AML) varies by cytogenetic group. Blood 84 [Suppl 1]:111a
6. Burnett AK, Wheatley K, Langabeer S, Walker H, Linch D, Goldstone AH, Hann I, Stevens RF (1997) Outcome of acute myeloid leukemias affecting core binding factors subunits: the UK MRC experience. Blood 90 [Suppl 1]:391a
7. Byrd JC, Weiss RB, Arthur DC, Lawrence D, Baer MR, Davey F, Trikha ES, Carroll AJ, Tantravahi R, Qumsiyeh M, Patil SR, Moore JO, Mayer RJ, Schiffer CA, Bloomfield CD (1997) Extramedullary leukemia adversly affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from cancer and leukemia groupB 8461. J Cin Oncol 15:466-475
8. Campana D, Pui C-H (1995) Detection of minimal residual disease in acute leukemia: methodological advances and clinical significance. Blood 85:1416-1434
9. Chomczynski P. Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
10. Downing JR, Head DR, Curio-Brint AM, Hulshof MG, Motroni TA, Raimondi SA, Carroll AJ, Drahkin HA (1993) An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the(8:21)(q22;q22) translocation. Blood 81:2860-2865
11. Erickson P, Gao J, Chang KS, Look T, Raimondi S, Lasher R, Trujillo J, Rowley J, Drabkin H (1992) Identification of breakpoints in t(8:21) acute myelogenous leukemia and isolation of a fusion transcript. AML1/ETO, with similarity to drosophila segmentation gene, runt. Blood 80:1825-1831
12. Ganesan TS, Rassool F, Guo AP, Th'ng KH, Dowding C, Hibbi JA, Young BD, White H, Kumaran TO, Galton DAG, Goldman JM (1986) Rearrangement of the bcr gene in Philadelphia chromosome-negative chronic myeloid leukemia. Blood 68:957-960
13. Ghaddar HM, Plunkett W, Kantarjian HM, Pierce S, Freireich EJ, Keating MJ, Estey EH (1994) Long-term results following treatment of newly diagnosed acute myelogenous leukemia with continuous-infusion high-dose cytosine arabinoside. Leukemia 8:1269-1274
14. Haas OA, Schwarzmeier JD, Nacheva E, Fischer P, Paietta E (1984) Investigations on karyotype evolution in patients with chronic myeloid leukemia (CML). Blut 48:33-43
15. Hurwitz CA, Raimondi SC, Head D, Krance R, Mirro J, Kalwinsky DK, Avers GD, Behm FG (1992) Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood 80:3182-3188
16. Kita K, Nakase K, Miwa H, Masuya M, Nishii K, Morita N, Takakura N, Otsuji A, Shirakawa S, Ueda T, Nasu K, Kyo T, Dohy H, Kamada N (1992) Phenotypical characteristics of acute myelocytic leukemia associated with the t(8:21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD 19 together with stem cell antigen CD34. Blood 80:470-477
17. Kozu T, Miyoshi H, Shimizu K, Maseki N, Kaneko Y, Asou H, Kamada N, Ohki M (1993) Junctions of the AML1/ MTG8(ETO) fusion are constant in t(8;21 ) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood 82:1270-1276
18. Kusec R, Laczika K, Knöbl P, Friedl J, Greinix H, Kahls P, Linkesch W, Schwarzinger I, Mitterbauer G, Purtscher B, Haas O, Lechner K, Jaeger U (1994) AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia 8:735-739
19. Kwok S, Higuchi R (1989) Avoiding false positives with the PCR. Nature 339:327-328
20. Maruyama F, Yang P, Stass SA, Cork A, Freireich AJ, Lee MS, Chang KS (1993) Detection of the AML1/ETO fusion transcript in the t(8;21) masked translocation in acute myelogenous leukemia. Cancer Res 53:4449-4451
21. Maruyama F, Stass SA, Estey EH, Cork A, Hirano M, Ino T, Freireich EJ, Yang P, Chang KS (1994) Detection of AML1/ ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia. Leukemia 8:40-45
22. Maseki N, Miyoshi H, Shimizu K, Homma C. Ohki M, Sakurai M, Kaneko Y (1993) The 8;21 chromosome translocation in acute myeloid leukemia is always detectable by molecular analysis using AML1. Blood 81:1573-1579
23. Mayer RJ, Davis RB. Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei E 3rd (1994) Intensive post remission therapy in adults with acute myeloid leukemia. N Engl J Med 331:896-903
24. Mitelman F (ed) (1991) An international system for human cytogenetic nomenclature. Karger, Basel
25. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M (1991) t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene. AML1. Proc Natl Acad Sci USA 88:10431-10434
26. Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y, Kamada N, Ohki M (1993) The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J 12:2715-2721
27. Ng S-Y, Gunning P, Eddy R, Ponte P, Leavitt J, Shows T, Kedes L (1985) Evolution of the functional human β-actin gene and its multi-pseudogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes. Mol Cell Biol 5:2720-2732
28. Nucifora G, Birn DJ, Erickson P, Gao J, LeBeau MM, Drabkin HA, Rowley JD (1993) Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21 ) acute myeloid leukemia. Blood 81:883-888
29. Nucifora G, Larson RA, Rowley JD (1993) Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 82:712-715
30. Nucifora G, Dickstein JI, Torbenson V, Roulston D, Rowley JD, Vardiman JW (1994) Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21). Leukemia 8:1533-1538
31. Nucifora G, Rowley JD (1994) The AML1 and ETO genes in acute myeloid leukemia with a t(8;21). Leukemia Lymphoma 14:353-362
32. Nucifora G, Rowley JD (1995) AML1 and the 8;21 and 3;21 translocations in acute and chronic leukemia. Blood 86:1-14
33. Porwit-MacDonald A, Janossy G, Ivory K, Swirsky D, Peters R. Wheatley K, Walker H, Turker A, Goldstone AH, Burnett A (1996) Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21). Blood 87:1162-1169
34. RItter M, Thiede C, Schaekel U, Schmidt M, Alpen B, Pascheberg U, Mohr B, Ehninger G, Neubauer A (1997) Comparison of polymerase chain reaction (PCR) und standard cytogenetics in detection of inversion (16) and translocation (8;21): results of a prospective investigation on 132 AML-patients. Onkologie 20 [Suppl 1]:450
35. Rowley JD (1990) Recurring chromosomal abnormalities in leukemia and lymphoma. Semin Hemalol 27:122-136
36. Sakurai M, Oshimura M, Kakti S, Sandherg AA (1974) 8-21 translocation and missing sex chromosomes in acute leukemia. Lancet 2:227-228
37. Sawyers CL (1997) Molecular genetics of acute leukemia. Lancet 349:196-200
38. Schiffer CA, Lee EJ, Tomiyasu T, Wiernik PH, Testa JR (1989) Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood 73:263-270
39. Schoch C, Haase D, Haferlach T, Gudat H, Buchner T, Freund M, Link H, Lengerfelder E, Wandt H, Sauerland MC, Loffler H, Fonatsch C (1996) Fifty-one patients with acute myeloid leukemia and translocation t (8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor. Leukemia 10:1288-1295
40. Seymour JF, Pierce SA, Kantarjian HM, Keating MJ, Estey EH (1994) Investigation of karyotypic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56). Leukemia 8:823-826
41. Shimizu K, Miyoshi H, Kozu T, Nagata J, Enomoto K, Maseki M, Kaneko Y, Ohki M (1992) Consistent disruption of the AML1 gene occurs within a single intron in the t(8;21) chromosomal translocation. Cancer Res 52:6945-6948
42. Swansbury GJ, Lawlwe SD, Alimena G, Arthur D, Berger R, Van den Berghe H, Bloomfield CD, de la Chappelle A, Dewald G, Garson OM, Hagemeijer A, Mitelman F, Rowley JD, Sakurai M (1994) Long-term survival in acute myelogenous leukemia: a second follow-up of the Fourth International Workshop on chromosomes in leukemia. Cancer Genet Cytogenet 73:1-7
43. Tashiro S, Kyo T, Tanaka K, Oguma N, Hashimoto T, Dohy H, Kamada N (1992) The prognostic value of cytogenetic analysis in patients with acute nonlymphocytic leukemia treated with the same intensive chemotherapy. Cancer 70:2809-2815
44. Zhang T, Hillion J, Tong JH, Cao Q, Chen SJ, Berger R, Chen Z (1994) AML-1 gene rearrangement and AML-1-ETO gene expression as molecular markers of acute myeloblastic leukemia with t(8;21). Leukemia 8:729-734